Resveratrol has also been found to inhibit CD4+ activation in vitro and in vivo [68], while cirsilineol, another phenolic compound, was proven to be a potential treatment for T-cell-mediated inflammatory bowel diseases due to its targeted activity on CD4+ cells [69]. The gene discussed is CD4; the disease is inflammatory bowel disease.